Center-Authored Papers

Filters: Author is Gandara, David R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Ou S-HI, Moon J, Garland LL, Mack PC, Testa JR, Tsao AS, Wozniak AJ, Gandara DR.  2015.  SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM).. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 10(2):387-91. Abstract
Bunn PA, Minna J, Augustyn A, Gazdar A, Ouadah Y, Krasnow MA, Berns A, Brambilla E, Rekhtman N, Massion PP et al..  2016.  Small Cell Lung Cancer: Can recent advances in biology and molecular biology be translated into improved outcomes? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 11(4):453-74.
Tsao AS, Scagliotti GV, Bunn PA, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan UA, McWilliams A, Tsao MS et al..  2016.  Scientific Advances in Lung Cancer 2015.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Abstract
R
Lara PN, Gandara DR, Redman MW.  2015.  Reply to "diminishing role of platinum-sensitivity status in patients with small cell lung cancer".. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 10(5):e36.
P
Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman MW, Gandara DR.  2011.  Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(11):1938-45. Abstract
M
L